Mochida Pharmaceutical Co., Ltd.

¥3,165As of Sun 8 Nov 2026, 12:00 UTC
TSE:4534Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR (0.42%)
Div yield 2.69%
ROE 6.77%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.07
PE TTM 12.21
TSR TTM 9.97%
Mkt cap ¥111.2B
ROIC 6.40%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥3,798
20.00%
(40.24%)
Hold 5|5|10|0|6
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
63.26
60.33
64.15
65.67
18.83%
10.96%
10.83%
16.26%
Revenue¥B
5.059
5.268
5.285
5.140
8.92%
9.40%
9.09%
7.40%
Peers (US$705.8M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.638
0.135
0.116
EBIT/Intx
1.058
1.396
1.371
Own earn%
(168.78)
141.28
132.04
Sh yield%
41.52
34.09
31.09
Owners
Insiders/Inst%
5.89
40.10
Short interest%
3.61
SBC / revenue%
4.58
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
24–28
$1 testx
—
Incr. ROIC%
33